饮食中铁的限制可改善小鼠镰状细胞贫血疾病严重程度的标志物。
Dietary iron restriction improves markers of disease severity in murine sickle cell anemia.
机构信息
Department of Pediatrics, Saint Louis University School of Medicine, St Louis, MO.
Molecular and Clinical Nutrition Section, Digestive Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases.
出版信息
Blood. 2021 Mar 18;137(11):1553-1555. doi: 10.1182/blood.2020006919.
Abstract
There is a Commentary on this article in this issue.
摘要
本期对这篇文章有评论。
相似文献
1
Dietary iron restriction improves markers of disease severity in murine sickle cell anemia.饮食中铁的限制可改善小鼠镰状细胞贫血疾病严重程度的标志物。
Blood. 2021 Mar 18;137(11):1553-1555. doi: 10.1182/blood.2020006919.
2
Dietary supplementation with docosahexanoic acid (DHA) increases red blood cell membrane flexibility in mice with sickle cell disease.用二十二碳六烯酸（DHA）进行膳食补充可增加镰状细胞病小鼠的红细胞膜柔韧性。
Blood Cells Mol Dis. 2015 Feb;54(2):183-8. doi: 10.1016/j.bcmd.2014.11.004. Epub 2014 Nov 25.
3
Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease.在镰状细胞病转基因小鼠模型中，膳食中的ω-3脂肪酸可预防血管病变。
Haematologica. 2015 Jul;100(7):870-80. doi: 10.3324/haematol.2015.124586. Epub 2015 May 1.
4
A comparison of erythrocyte characteristics in sickle cell syndromes in Jamaica.牙买加镰状细胞综合征患者红细胞特征的比较。
Br J Haematol. 1972 Aug;23(2):205-13. doi: 10.1111/j.1365-2141.1972.tb03473.x.
5
Overt iron deficiency in sickle cell disease.镰状细胞病中的明显缺铁
Arch Intern Med. 1982 Sep;142(9):1621-4.
6
Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.α地中海贫血改变镰状细胞病中的红细胞异质性。
J Clin Invest. 1985 May;75(5):1632-7. doi: 10.1172/JCI111870.
7
Improvement of sickle cell anemia by iron-limited erythropoiesis.通过铁限制红细胞生成改善镰状细胞贫血。
Am J Hematol. 1994 Oct;47(2):74-81. doi: 10.1002/ajh.2830470203.
8
Serum Hepcidin Concentration in Individuals with Sickle Cell Anemia: Basis for the Dietary Recommendation of Iron.血清铁调素浓度在镰状细胞贫血个体中的变化：铁的饮食推荐依据。
Nutrients. 2018 Apr 17;10(4):498. doi: 10.3390/nu10040498.
9
Red blood cell counts and indices in sickle cell trait in a black American population.美国黑人人群中镰状细胞性状的红细胞计数及指数
Hemoglobin. 1985;9(1):65-7. doi: 10.3109/03630268508996983.
10
Sickle cell anemia: a potential nutritional approach for a molecular disease.镰状细胞贫血：一种针对分子疾病的潜在营养疗法。
Nutrition. 2000 May;16(5):330-8. doi: 10.1016/s0899-9007(00)00257-4.
引用本文的文献
1
Iron and the Intestinal Microbiome.铁与肠道微生物群
Adv Exp Med Biol. 2025;1480:345-360. doi: 10.1007/978-3-031-92033-2_22.
2
Relationships Between Markers of Iron Status and Hematological Parameters in Patients With Sickle Cell Disease.镰状细胞病患者铁状态标志物与血液学参数之间的关系
Adv Hematol. 2024 Dec 3;2024:9872440. doi: 10.1155/ah/9872440. eCollection 2024.
3
Vamifeport: Monography of the First Oral Ferroportin Inhibitor.瓦米非泊：首款口服铁转运蛋白抑制剂专论
J Clin Med. 2024 Sep 18;13(18):5524. doi: 10.3390/jcm13185524.
4
Ferroptosis as an emerging target in sickle cell disease.铁死亡作为镰状细胞病的一个新兴靶点。
Curr Res Toxicol. 2024 Jun 18;7:100181. doi: 10.1016/j.crtox.2024.100181. eCollection 2024.
5
Iron Absorption: Molecular and Pathophysiological Aspects.铁吸收：分子与病理生理学方面
Metabolites. 2024 Apr 17;14(4):228. doi: 10.3390/metabo14040228.
6
Activation of Intestinal HIF2α Ameliorates Iron-Refractory Anemia.肠道 HIF2α 的激活可改善铁难治性贫血。
Adv Sci (Weinh). 2024 Mar;11(12):e2307022. doi: 10.1002/advs.202307022. Epub 2024 Jan 20.
7
The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease.镰状细胞病中凝血、补体、铁和炎症的无形链条。
Curr Opin Hematol. 2023 Sep 1;30(5):153-158. doi: 10.1097/MOH.0000000000000773. Epub 2023 Jul 14.
8
Iron Deficiency and Iron Deficiency Anemia: Potential Risk Factors in Bone Loss.缺铁和缺铁性贫血：骨丢失的潜在危险因素。
Int J Mol Sci. 2023 Apr 7;24(8):6891. doi: 10.3390/ijms24086891.
9
Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies.用于镰状细胞病基因治疗的新型慢病毒载体，结合了基因添加和基因沉默策略。
Mol Ther Nucleic Acids. 2023 Mar 22;32:229-246. doi: 10.1016/j.omtn.2023.03.012. eCollection 2023 Jun 13.
10
Food Consumption of People with Sickle Cell Anemia in a Middle-Income Country.镰状细胞贫血患者在中等收入国家的食物消费。
Nutrients. 2023 Mar 19;15(6):1478. doi: 10.3390/nu15061478.
本文引用的文献
1
Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia.口服铁调素抑制剂可改善β-地中海贫血模型中的无效红细胞生成。
J Clin Invest. 2019 Dec 9;130(1):491-506. doi: 10.1172/JCI129382.
2
Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.自动化去氧条件下镰状细胞病患者镰变的快速可重现性特征。
Am J Hematol. 2019 May;94(5):575-584. doi: 10.1002/ajh.25443. Epub 2019 Mar 8.
3
Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia.溶血标志物在溶血性贫血鉴别诊断与管理中的临床应用
Dis Markers. 2015;2015:635670. doi: 10.1155/2015/635670. Epub 2015 Dec 27.
4
Intestine-specific Disruption of Hypoxia-inducible Factor (HIF)-2α Improves Anemia in Sickle Cell Disease.肠道特异性破坏缺氧诱导因子（HIF）-2α可改善镰状细胞病的贫血症状。
J Biol Chem. 2015 Sep 25;290(39):23523-7. doi: 10.1074/jbc.C115.681643. Epub 2015 Aug 19.
5
Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice.降低 TMPRSS6 可改善小鼠的血色病和β地中海贫血。
J Clin Invest. 2013 Apr;123(4):1531-41. doi: 10.1172/JCI66969. Epub 2013 Mar 25.
6
Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload.迷你肝铁素是经过合理设计的小肽，可模拟肝铁素在小鼠体内的活性，可能对治疗铁过载有用。
J Clin Invest. 2011 Dec;121(12):4880-8. doi: 10.1172/JCI57693.
7
Regulation of serum hepcidin levels in sickle cell disease.镰状细胞病中血清铁调素水平的调节
Haematologica. 2009 Jun;94(6):885-7. doi: 10.3324/haematol.2008.003152.
8
Sickle cell anemia a molecular disease.镰状细胞贫血是一种分子疾病。
Science. 1949 Nov 25;110(2865):543-8. doi: 10.1126/science.110.2865.543.
9
Knockout-transgenic mouse model of sickle cell disease.镰状细胞病的基因敲除转基因小鼠模型
Science. 1997 Oct 31;278(5339):873-6. doi: 10.1126/science.278.5339.873.
10
Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis.镰状细胞病患者可溶性血管细胞黏附分子-1水平升高及其在血管闭塞性危象期间的特异性增加。
Clin Immunol Immunopathol. 1996 Oct;81(1):96-8. doi: 10.1006/clin.1996.0163.
Zotero 插件